Stock Market News Stock Market News
  • Dow
  • S&P
  • Nasdaq
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Crypto
  • Forex
  • Tech
  • Politics
  • +

4 days MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN Zacks

Monopar stock skyrockets 384% in three months following a licensing deal with AstraZeneca for a late-stage Wilson Disease candidate.

Alexion (ALXN) · Biotech

  X     

4 hours Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

5 hours Huge New Year’s Insider Buying From Warren Buffett and Others 24/7 Wall St.

   X     

7 hours AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell? Zacks

   X     

2 days A successful VC predicts what the next 10 years in the venture capital industry will look like Business Insider

   X     

3 days Here’s Why Arcutis Stock More Than Doubled in Market Value in One Year Zacks

   X     

3 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

4 days Looks Like Tech will lead this year again. Reddit

   X     

4 days Neumora Therapeutics’ stock craters after trial of major depressive disorder fails to meet main goals MarketWatch

   X     

4 days 5 Large Drug Stocks to Keep An Eye On in the New Year Zacks

   X     

4 days Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Zacks

   X     

5 days All You Need to Know About Puma Biotech (PBYI) Rating Upgrade to Strong Buy Zacks

   X     

6 days Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

   X     

7 days This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap. Yahoo Finance

   X     

7 days Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

1 week Friday’s Insider Activity: Top Execs Make Moves in Biotech and Retail Investing.com

   X     

1 week Buffett Is Still Buying, Plus Insiders Love These 2 Biotech Stocks 24/7 Wall St.

   X     

1 week Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy Seeking Alpha

   X     

2 weeks How Tarsus Pharmaceuticals’ Unique Inspiration Is Driving A Triple-Digit Run Investor's Business Daily

   X     

2 weeks 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone Seeking Alpha

   X     

2 weeks 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks

   X     

2 weeks Should You Invest in the VanEck Biotech ETF (BBH)? Zacks

   X     

2 weeks Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

   X     

2 weeks 5 Biotech Breakthrough Stocks to Watch in 2025 Zacks

   X     

2 weeks Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

   X     

2 weeks Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance

   X     

2 weeks This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? Yahoo Finance

   X     

2 weeks Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks

   X     

3 weeks 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks

   X     

3 weeks KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks

   X     

3 weeks Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks

   X     

3 weeks Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily

   X     

3 weeks Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks

   X     

3 weeks 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance

   X     

3 weeks Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

   X     

3 weeks How to play a potential biotech breakout in 2025 with options CNBC

   X     

3 weeks 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

   X     

3 weeks 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks

   X     

3 weeks ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

   X     

3 weeks ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

   X     

3 weeks Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance

   X     

3 weeks KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks

   X     

4 weeks RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead MarketWatch

   X     

4 weeks The Ultimate Biotech Stock to Buy With $500 Right Now Yahoo Finance

   X     

4 weeks Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

   X     

4 weeks Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More Zacks

   X     

4 weeks Investors Slaughter Q32 Bio On A ‘Messy’ Update In Eczema, Alopecia Treatment Investor's Business Daily

   X     

4 weeks Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug Investor's Business Daily

   X     

4 weeks Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell? Zacks

   X     

4 weeks NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug Investor's Business Daily

   X     

4 weeks CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease MarketWatch

   X     
More news +
Home | Contact
  • X

© 2025 The Stock Market News